Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

NCT05701774 · clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
83
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Soleno Therapeutics, Inc.